Deutsche Bank Ag\ Y M Abs Therapeutics, Inc. Transaction History

Deutsche Bank Ag\

$240 Billion
Q3 2024

A detailed history of Deutsche Bank Ag\ transactions in Y M Abs Therapeutics, Inc. stock. As of the latest transaction made, Deutsche Bank Ag\ holds 21,194 shares of YMAB stock, worth $201,978. This represents 0.0% of its overall portfolio holdings.

Number of Shares

21,194

Previous 22,536 5.95%

Holding current value

$201,978

Previous $272,000 2.21%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$9.95 - $15.39 $13,352 - $20,653	-1,342 Reduced 5.95%	21,194 $278,000
Q2 2024 Aug 14, 2024	BUY	$11.6 - $17.25 $45,205 - $67,223	3,897 Added 20.91%	22,536 $272,000
Q1 2024 May 15, 2024	SELL	$6.57 - $18.69 $164 - $467	-25 Reduced 0.13%	18,639 $303,000
Q4 2023 Feb 14, 2024	BUY	$4.88 - $7.42 $2,483 - $3,776	509 Added 2.8%	18,664 $127,000
Q2 2023 Aug 14, 2023	SELL	$5.68 - $10.34 $31,058 - $56,539	-5,468 Reduced 23.15%	18,155 $123,000
Q1 2023 May 15, 2023	BUY	$2.83 - $5.11 $17,520 - $31,636	6,191 Added 35.52%	23,623 $118,000
Q4 2022 Feb 13, 2023	BUY	$3.0 - $15.17 $738 - $3,731	246 Added 1.43%	17,432 $85,000
Q3 2022 Nov 14, 2022	SELL	$13.96 - $19.67 $741,974 - $1.05 Million	-53,150 Reduced 75.57%	17,186 $248,000
Q2 2022 Aug 11, 2022	SELL	$8.22 - $15.13 $1.93 Million - $3.55 Million	-234,706 Reduced 76.94%	70,336 $1.06 Million
Q1 2022 May 13, 2022	BUY	$6.55 - $17.42 $1.84 Million - $4.89 Million	280,640 Added 1150.07%	305,042 $3.62 Million
Q4 2021 Feb 11, 2022	BUY	$15.51 - $29.31 $23,962 - $45,283	1,545 Added 6.76%	24,402 $396,000
Q3 2021 Nov 04, 2021	SELL	$27.47 - $37.31 $141,250 - $191,848	-5,142 Reduced 18.36%	22,857 $653,000
Q2 2021 Aug 11, 2021	BUY	$25.45 - $37.64 $33,823 - $50,023	1,329 Added 4.98%	27,999 $946,000
Q1 2021 May 13, 2021	SELL	$29.16 - $51.96 $65,639 - $116,961	-2,251 Reduced 7.78%	26,670 $806,000
Q4 2020 Feb 16, 2021	BUY	$37.86 - $54.26 $253,927 - $363,921	6,707 Added 30.19%	28,921 $1.43 Million
Q3 2020 Nov 12, 2020	SELL	$35.13 - $43.62 $177,792 - $220,760	-5,061 Reduced 18.56%	22,214 $853,000
Q2 2020 Aug 13, 2020	SELL	$23.66 - $49.53 $646,249 - $1.35 Million	-27,314 Reduced 50.04%	27,275 $1.18 Million
Q1 2020 May 14, 2020	SELL	$14.39 - $35.8 $1.53 Million - $3.82 Million	-106,660 Reduced 66.15%	54,589 $1.43 Million
Q4 2019 Feb 14, 2020	BUY	$23.81 - $33.78 $3.69 Million - $5.24 Million	155,044 Added 2498.69%	161,249 $5.04 Million
Q3 2019 Nov 14, 2019	SELL	$21.57 - $31.37 $213,909 - $311,096	-9,917 Reduced 61.51%	6,205 $160,000
Q2 2019 Aug 14, 2019	BUY	$19.51 - $28.31 $143,359 - $208,021	7,348 Added 83.75%	16,122 $368,000
Q1 2019 May 15, 2019	SELL	$18.21 - $26.21 $12,346 - $17,770	-678 Reduced 7.17%	8,774 $228,000
Q4 2018 Feb 14, 2019	BUY	$15.41 - $28.92 $145,655 - $273,351	9,452 New	9,452 $191,000

Others Institutions Holding YMAB

# of Institutions

107

Shares Held

24.5M

Call Options Held

40.3K

Put Options Held

400

View Full List

About Y-mAbs Therapeutics, Inc.

Ticker YMAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,719,500
Market Cap $417M
Description
Y-mAbs Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel antibody based therapeutic products for the treatment of cancer in the United States. It offers DANYELZA, a monoclonal antibody in combination with granulocyte-macrophage colony-stimulating factor for the treatment o...

More about YMAB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.

Account